International
Reviews
Forum
Lay Forum
Reference Library
Bibliography
Reference list - Prostate – Screening, benign enlargement and cancer 1. Auvinen A, Tammela T, Stenman U-H, Uusi-Erkkila I, Leinonen J, Schroder FH et al. Screening for prostate cancer using serum prostate-specific antigen: A randomised, population-based pilot study in Finland. British Journal of Cancer Vol 74.(4.) (pp.568.-572.), 1996. 2. Bangma CH, Blijenberg BG, Schroder FH. Prostate-specific antigen: Its clinical use and application in screening for prostate cancer. Scandinavian Journal of Clinical & Laboratory Investigation - Supplement Vol 55.(221.) (pp.35.-44.), 1995. 3. Bangma CH, Rietbergen JW, Kranse R, Blijenberg BG, Petterson K, Schroder FH et al. The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population. Journal d.Urologie Vol 157.(6.) (pp.2191.-2198.), 1997. 4. Beemsterboer PM, Kranse R, De KH, Habbema JF, Schroder FH. Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam). International Journal of Cancer Vol 84.(4.) (pp.437.-441.), 1999. 5. Carlson GD, Calvanese CB, Partin AW. An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer: results on 4298 cases. Urology 1998;52:455-61. 6. Carter HB, Pearson JD, Metter EJ, Chan DW, Andres R, Fozard JL et al. Longitudinal evaluation of serum androgen levels in men with and without prostate cancer. Prostate 1995;27:25-31. back to reference library menu
2. Bangma CH, Blijenberg BG, Schroder FH. Prostate-specific antigen: Its clinical use and application in screening for prostate cancer. Scandinavian Journal of Clinical & Laboratory Investigation - Supplement Vol 55.(221.) (pp.35.-44.), 1995.
3. Bangma CH, Rietbergen JW, Kranse R, Blijenberg BG, Petterson K, Schroder FH et al. The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population. Journal d.Urologie Vol 157.(6.) (pp.2191.-2198.), 1997.
4. Beemsterboer PM, Kranse R, De KH, Habbema JF, Schroder FH. Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam). International Journal of Cancer Vol 84.(4.) (pp.437.-441.), 1999.
5. Carlson GD, Calvanese CB, Partin AW. An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer: results on 4298 cases. Urology 1998;52:455-61.
6. Carter HB, Pearson JD, Metter EJ, Chan DW, Andres R, Fozard JL et al. Longitudinal evaluation of serum androgen levels in men with and without prostate cancer. Prostate 1995;27:25-31.
back to reference library menu
